Please complete the CAPTCHA to continue
@ark-tdm.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Raj Singh is listed as Lifesciences Strategy, Innovation, R&D Medical Diagnostics at ARK Diagnostics, Inc., based in San Jose, California, United States. AeroLeads shows a work email signal at ark-tdm.com and a matched LinkedIn profile for Raj Singh.
Raj Singh previously worked as Sr. Director, Strategy and Innovation at Ark Diagnostics, Inc. and Strategic Advisor and Market Development at Goryo Chemical, Inc. Raj Singh holds Ph.D., Bio-Organic Chemistry from Columbia University.
This section adds company-level context without repeating Raj Singh's masked contact details.
AeroLeads found 1 current-domain work email signal for Raj Singh. Compare company email patterns before reaching out.
Entrepreneurial, Innovative, Customer Centric, R&D leader for disruptive platforms in lifesciences.Experienced in scientific strategy, competitive intelligence, portfolio management and content development. IVD 510k, Quality and QC processes, Organic and Analytical Chemistry expertiseReviewer in several NIH SBIR/STTR study sections, infectious disease and point of care device development Sr Director Reagents and Biology at Caliper Lifesciences through acquisition by Perkin Elmer headed R&D creating and implementing cost effective, easy to implement reagent and assay content to all of PKI technology platforms using microfluidics, automation, preclinical imaging and next gen sequencing sample preparation addressing the life sciences, medical diagnostics, agbio and environmental market segments. Head of Chemistry at DiscoveRx, launched numerous products from concept to commercialization targeting the HTS and HCS drug discovery market segments with optical readouts. Creation, acquisition, licensing and monetization of IP. Led Metabolomics and Proteomics at Surromed to devise infrastructure for mass spectrometric, laser scanning cytometry, immunoassay and clinical diagnostics based screening of biological samples for biomarker discovery targeted towards patient stratification. Developed assay technologies for companion medical diagnostics in IVD and life science RUO instrumentation. Team behind LOCI/ALPHA which has had 3+ billion datapoints screened, culminating with melanoma drug Zelboraf NDA (Roche) and launched by Siemens for clinical diagnostics. Co-authored a number of publications and co-invented over 25 patents almost all of which have resulted in revenue generating products. PhD under Prof. Ronald Breslow (Columbia University) where precursors to anticancer drug Vorinostat (Zolinza, Merck ) were synthesized and seminal epigenetic assays developed at Memorial Sloan Kettering Hospital. Specialties: Assay Guru, Competitive analysis, Intellectual property, design of experiments, organic. physical and analytical chemistry, drug discovery, innovation, outsourcing, customer and CRO liaison, newborn screening, rare diseases, IVD FDA clearances, microfluidics and point of care devices
Listed skills include Intellectual Property, Competitive Analysis, Outsourcing, Design Of Experiments, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Provide medical, clinical, technological and scientific input in next generation assays and platforms. Market research, business development in Therapeutic Drug Monitoring, Drugs of Abuse Screening, and strategy pertaining to niche new product development, Technical subject matter expertise in assays and device design. Prior art patent and literature.
Sapporo, Hokkaido, JP
Strategic Advisor, market expansion of unique reagents for fluorescent imaging establish distributorship, corporate presentation, trade shows and business development
Durham, NC, US
Biochemistry Expertise, Grant ideation, PI on several SBIR grants, Novel assays on digital microfluidics platform, Pharmaceutical partnerships for rare disease assays, competitive market analysis for point of care and high throughput systems. Expansion of product portfolio and intellectual property support. Mentor junior employees.
Waltham, Massachusetts, US
Fremont, CA, US
Drug Discovery and Life Sciences industry trend analytics for market share and competitive positioning of EFC technology for service and commercial strategies for growthSpearhead all intellectual property related matters encompassing IP landscape, interpretation to pertinent stakeholders, freedom to operate due diligence, completeness of invention.
Forchheim, DE
Developed homogeneous sandwich assays based on singlet oxygen channeling (FOCI). Design, synthesis, dyeing of nanoparticles with photoactivatable substrates, polymer coating and assays. Amplified homogeneous proximity assays LOCI, singlet oxygen cleavable protected biotin derivatives, fluorescent lanthanide chelates. LOCI has been commercialized as ALPHA.
Quick answers generated from the profile data available on this page.
Raj Singh works for ARK Diagnostics, Inc..
Raj Singh is listed as Lifesciences Strategy, Innovation, R&D Medical Diagnostics at ARK Diagnostics, Inc..
AeroLeads has found 1 work email signal at @ark-tdm.com for Raj Singh at ARK Diagnostics, Inc..
Raj Singh is based in San Jose, California, United States while working with ARK Diagnostics, Inc..
Raj Singh has worked for Ark Diagnostics, Inc., Goryo Chemical, Inc, Baebies, Athaena Biomedical Systems, and Revvity.
You can use AeroLeads to view verified contact signals for Raj Singh at ARK Diagnostics, Inc., including work email, phone, and LinkedIn data when available.
Raj Singh holds Ph.D., Bio-Organic Chemistry from Columbia University.
Raj Singh is listed with skills including Intellectual Property, Competitive Analysis, Outsourcing, Design Of Experiments, Biotechnology, Drug Discovery, Molecular Imaging, and Biomarkers.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts